Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Evolan Pharma AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 948,637 Less Arrow 736,919 Less Arrow 668,681
Financial expenses 8,469 Less Arrow 1,763 Less Arrow 1,349
Earnings before taxes 287,531 Less Arrow 233,878 Less Arrow 194,930
EBITDA 400,047 Less Arrow 306,627 Less Arrow 265,027
Total assets 1,017,471 Less Arrow 863,471 Less Arrow 552,285
Current assets 744,003 Less Arrow 492,157 Less Arrow 353,839
Current liabilities 227,609 Less Arrow 213,747 Less Arrow 153,067
Equity capital 730,968 Less Arrow 527,496 Less Arrow 365,739
- share capital 100 Equal arrow 100 Equal arrow 100
Employees (average) 29 Less Arrow 27 Equal arrow 27

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 71.8% Less Arrow 61.1% More Arrow 66.2%
Turnover per employee 32,712 Less Arrow 27,293 Less Arrow 24,766
Profit as a percentage of turnover 30.3% More Arrow 31.7% Less Arrow 29.2%
Return on assets (ROA) 29.1% Less Arrow 27.3% More Arrow 35.5%
Current ratio 326.9% Less Arrow 230.3% More Arrow 231.2%
Return on equity (ROE) 39.3% More Arrow 44.3% More Arrow 53.3%
Change turnover 211,718 Less Arrow 68,238 More Arrow 125,269
Change turnover % 29% Less Arrow 10% More Arrow 23%
Chg. No. of employees 2 Less Arrow 0 Equal arrow 0
Chg. No. of employees % 7% Less Arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.